COMMUNIQUÉS West-GlobeNewswire

-
Sotera Health Announces Second-Quarter 2025 Earnings Release Date
28/07/2025 -
La Commission européenne approuve l’IMBRUVICA® (ibrutinib) comme premier traitement ciblé pour les patients atteints d’un lymphome à cellules du manteau non préalablement traité et éligibles à une autogreffe de cellules souches
28/07/2025 -
Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter
28/07/2025 -
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)
28/07/2025 -
LENZ Therapeutics Announces NMPA Submission of New Drug Application for LNZ100 in China for the Treatment of Presbyopia
28/07/2025 -
Immutep Announces Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025
28/07/2025 -
OncoC4 Announces New Preclinical Data Highlighting ONC-841, a Novel SIGLEC 10 Antibody, as a Potential New Class of Therapeutics for Alzheimer’s Disease
28/07/2025 -
Apyx Medical Corporation Announces Launch of Renuvion® in China
28/07/2025 -
Chiesi Global Rare Diseases Spotlights the Profound Impact of Epidermolysis Bullosa in the Film “Living Between Pain and Hope” as part of “The Next Frontier,” a New Series Presented by the Biotechnology Innovation Organization
28/07/2025 -
Soleno Therapeutics to Report Second Quarter 2025 Financial Results on August 6, 2025, at 4:30 PM ET
28/07/2025 -
UroGen Announces Publication of Phase 3b Study Results Demonstrating the Feasibility of Home Instillation of ZUSDURI™ for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer in Reviews in Urology
28/07/2025 -
Acumen Pharmaceuticals Presents Studies Showing the Utility of a pTau217 Assay in Screening for a Phase 2 Alzheimer’s Disease Trial and Validates Sabirnetug Oligomer-Selectivity, at the Alzheimer’s Association International Conference (AAIC) 2025
28/07/2025 -
Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results
28/07/2025 -
NetraMark Signs Contract with AlgoTx to Enhance Clinical Trial Design for ATX01
28/07/2025 -
Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy
28/07/2025 -
Phathom Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide Business Update on Thursday, August 7, 2025
28/07/2025 -
Consortium Led by Nordic Capital and Permira Will Make All-Cash Recommended Purchase Offer for Bavarian Nordic
28/07/2025 -
Dogecoin Cash Inc. Confirms Filing of Provisional Patent for Dogecoin Protocol Framework
28/07/2025 -
Roche presents new insights in Alzheimer’s disease research across its diagnostics and pharmaceutical portfolios at AAIC
28/07/2025
Pages